Kali phosphoricum

DIBASIC POTASSIUM PHOSPHATE ORAL HUMAN OTC DRUG

Kali phosphoricum is an FDA drug label for the active ingredient DIBASIC POTASSIUM PHOSPHATE manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231113.

Generic name
DIBASIC POTASSIUM PHOSPHATE
Manufacturer
Boiron
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
0220-2964
Application
N/A
Label effective
20231113

Active ingredients

Kali phosphoricum 12C (**contains 0.443 mg of the active ingredient per pellet)

Indications & Usage

Tension Headaches Associated With Intellectual Fatigue*

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Contraindications

Not available.

Warnings

Not available.

Adverse Reactions

Not available.

More products with the same ingredient

DIBASIC POTASSIUM PHOSPHATE

Kali Phos

Hylands Inc. View label